Skip to main content

Research, innovation and technological excellence

Goal 3
Goal 3

Ensure healthy lives and promote well-being for all at all ages

Goal 9
Goal 9

Build resilient infrastructure, promote inclusive and sustainable industrialization and foster innovation

Goal 17
Goal 17

Strengthen the means of implementation and revitalize the global partnership for sustainable development

Diasorin’s commitment

A key factor in Diasorin’s success is the constant identification and selection of new products aimed at expanding the range offered to customers.
The Innovation Process ensures the organic involvement of all possible resources in new ideas for kits and tools, to ensure that excellence in innovation is achieved, even in new clinical areas.

The current Corporate Innovation Process also makes it possible to anticipate certain key analyses, to evaluate ex-ante risks and opportunities regarding investment and development times.

Actions taken

Creation and implementation of a shared process for Product Development
3-level Stage & Gate Assessment


From the need to guarantee an organic approach to new opportunities, a process shared by all Group companies was created, whereby Product Development work can only begin for projects that are profitable in terms of value and innovation.

Each project is evaluated through a 3-level Stage & Gate structure, in which the idea is analyzed according to 6 analytical axes:

  • Strategic Fit/Rationale
  • Market dimensions
  • Economics
  • Technical feasibility
  • Regulatory, Quality and Clinical Affairs
  • Project Management and risk assessment

Related disclosures:
GRI 3: Material topics